BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 32124117)

  • 21. Update on intrathecal management of cerebral vasospasm: a systematic review and meta-analysis.
    Grossen AA; Ernst GL; Bauer AM
    Neurosurg Focus; 2022 Mar; 52(3):E10. PubMed ID: 35231885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic Approaches for Cerebrovascular Dysfunction After Aneurysmal Subarachnoid Hemorrhage: An Update and Future Perspectives.
    Torregrossa F; Grasso G
    World Neurosurg; 2022 Mar; 159():276-287. PubMed ID: 35255629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials.
    Dayyani M; Sadeghirad B; Grotta JC; Zabihyan S; Ahmadvand S; Wang Y; Guyatt GH; Amin-Hanjani S
    Stroke; 2022 Jun; 53(6):1993-2005. PubMed ID: 35354302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia.
    Nagahama Y; Allan L; Nakagawa D; Zanaty M; Starke RM; Chalouhi N; Jabbour P; Brown RD; Derdeyn CP; Leira EC; Broderick J; Chimowitz M; Torner JC; Hasan D
    J Neurosurg; 2018 Sep; 129(3):702-710. PubMed ID: 29099296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 1].
    Romero Kräuchi O; Verger Bennasar AM
    Rev Esp Anestesiol Reanim; 2011 Apr; 58(4):230-5. PubMed ID: 21608279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of cerebral blood flow velocities during treatment for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage.
    Rouanet C; Chaddad F; Freitas F; Miranda M; Vasconcellos N; Valiente R; Muehlschlegel S; Silva GS
    Neurocrit Care; 2022 Feb; 36(1):226-239. PubMed ID: 34286467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Steiger HJ; Ensner R; Andereggen L; Remonda L; Berberat J; Marbacher S
    Acta Neurochir (Wien); 2022 Mar; 164(3):811-821. PubMed ID: 35138488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
    J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of temporary clipping during aneurysm surgery on the incidence of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Malinova V; Schatlo B; Voit M; Suntheim P; Rohde V; Mielke D
    J Neurosurg; 2018 Jul; 129(1):84-90. PubMed ID: 28946178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Survey on Monitoring and Management of Cerebral Vasospasm and Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: The Mantra Study.
    Picetti E; Bouzat P; Bader MK; Citerio G; Helbok R; Horn J; Macdonald RL; McCredie V; Meyfroidt G; Righy C; Robba C; Sharma D; Smith WS; Suarez JI; Udy A; Wolf S; Taccone FS
    J Neurosurg Anesthesiol; 2024 Jul; 36(3):258-265. PubMed ID: 37254166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Traumatic brain injury and intracranial hemorrhage-induced cerebral vasospasm: a systematic review.
    Al-Mufti F; Amuluru K; Changa A; Lander M; Patel N; Wajswol E; Al-Marsoummi S; Alzubaidi B; Singh IP; Nuoman R; Gandhi C
    Neurosurg Focus; 2017 Nov; 43(5):E14. PubMed ID: 29088959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Update on the Efficacy and Safety Profile of Clazosentan in Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Song J; Xue YQ; Wang YJ; Xu P; Sun DK; Chen W
    World Neurosurg; 2019 Mar; 123():e235-e244. PubMed ID: 30496924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolution of invasive cerebral vasospasm treatment in patients with spontaneous subarachnoid hemorrhage and delayed cerebral ischemia-continuous selective intracarotid nimodipine therapy in awake patients without sedation.
    Paľa A; Schneider M; Brand C; Pedro MT; Özpeynirci Y; Schmitz B; Wirtz CR; Kapapa T; König R; Braun M
    Neurosurg Rev; 2019 Jun; 42(2):463-469. PubMed ID: 29804157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventive Effect of Clazosentan against Cerebral Vasospasm after Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage in Japanese and Korean Patients.
    Fujimura M; Joo JY; Kim JS; Hatta M; Yokoyama Y; Tominaga T
    Cerebrovasc Dis; 2017; 44(1-2):59-67. PubMed ID: 28463833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic and Humanistic Burden of Cerebral Vasospasm and Its Related Complications after Aneurysmal Subarachnoid Hemorrhage: A Systematic Literature Review.
    Thompson JC; Chalet FX; Manalastas EJ; Hawkins N; Sarri G; Talbot DA
    Neurol Ther; 2022 Jun; 11(2):597-620. PubMed ID: 35441974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Perfusion Computed Tomography Scan for Prediction of Vasospasm and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.
    Starnoni D; Maduri R; Hajdu SD; Pierzchala K; Giammattei L; Rocca A; Grosfilley SB; Saliou G; Messerer M; Daniel RT
    World Neurosurg; 2019 Oct; 130():e743-e752. PubMed ID: 31284055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and feasibility of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Shan T; Zhang T; Qian W; Ma L; Li H; You C; Xie X
    J Neurol; 2020 Jun; 267(6):1577-1584. PubMed ID: 30739182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Cilostazol in Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage-A Systematic Review, Meta-Analysis, and Trial Sequential Analysis.
    Bohara S; Garg K; Singh Rajpal PM; Kasliwal M
    World Neurosurg; 2021 Jun; 150():161-170. PubMed ID: 33631387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage with Asymptomatic Angiographic Vasospasm on Admission.
    Aldakkan A; Mansouri A; Jaja BN; Alotaibi NM; Macdonald RL;
    World Neurosurg; 2017 Jan; 97():199-204. PubMed ID: 27717776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.